Medtronic scientists develop artificial heart valve

09/27/2009 | Press Democrat (Santa Rosa, Calif.), The

Researchers and engineers at Medtronic are working on an artificial device designed to replace diseased heart valves of patients who are not qualified to undergo open-heart surgery. Medtronic thinks the worldwide market for synthetic heart valve, which can be implanted via a patient's femoral artery using a tube-and-wire catheter tool, could reach $3.5 billion.

View Full Article in:

Press Democrat (Santa Rosa, Calif.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY